RACHEL CHAMBERLIN: Open Payments
NPI 1952817835 · HERMITAGE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$687 in 20 payments from 8 companies in 2025. Trend: 2023 $456 · 2024 $425 · 2025 $687
Food & beverage: $687
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $225 |
| Inspire Medical Systems, Inc. | 2 | $165 |
| Regeneron Healthcare Solutions, Inc. | 3 | $89 |
| Optinose US, Inc. | 3 | $79 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Hikma Pharmaceuticals USA | 2 | $34 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: DUPIXENT, INSPIRE, Xhance, NEFFY, Ryaltris, FASENRA, NUCALA, TEZSPIRE.
Industry payments across TN — which companies pay providers there.
